or
forgot password

    • cancer clinical trials in newport news, VA

    • A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer
    Virginia Oncology Associates
    Newport News, Virginia 23606
    ER Positive, Her2 Negative Breast Cancer Patients, Triple Negative Breast Cancer Patients
    Eribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast Cancer
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Estrogen Receptor Positive Tumor, Breast Cancer
    A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Multiple Myeloma, Solid Tumors, Non-Small Cell Lung Cancer
    Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
    Urology of Virginia
    Newport News, Virginia 23606
    Prostate Cancer Metastatic, Hormone Refractory Prostate Cancer
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim
    Sandoz Investigational Site
    Newport News, Virginia 23601
    Chemotherapy-induced Neutropenia, Breast Cancer
    Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute
    First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Urothelial Carcinoma
    Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
    Urology of Virginia
    Newport News, Virginia 23606
    Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
    Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
    Urology of Virginia
    Newport News, Virginia 23606
    Prostate Cancer
    OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Prostate Cancer, Metastatic Castrate-Resistant Prostate Cancer, PSA
    Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), Low to Intermediate-1 MDS
    Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Breast Cancer
    Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Breast Cancer
    Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Malignant Mesothelioma
    Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Breast Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Virginia Oncology Associates - Newport News
    Newport News, Virginia 23606
    Breast Cancer
    Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Breast Neoplasms, Neoplasms, Hormone-Dependent
    S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Peninsula Cancer Institute - Newport News Office
    Newport News, Virginia 23601
    Lung Cancer
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Small Cell Lung Cancer
    Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Prostate Cancer, Hormone Refractory Prostate Cancer
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Non-Small Cell Lung Cancer
    Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Carcinoma, Non-Small-Cell Lung
    Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin’s Lymphoma and Solid Tumors
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Non-Hodgkin's Lymphoma,, Solid Tumors
    Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Breast Cancer
    Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Virginia Oncology Associates

    Trial Locations
    Virginia Oncology Associates
    Peninsula Cancer Institute
    Carcinoma, Non-Small Cell Lung
    Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary
    Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Metastatic Breast Cancer
    5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Rectal Cancer, Cancer of the Rectum, Colorectal Cancer
    Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
    Peninsula Cancer Center
    Newport News, Virginia 23601
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Small Cell Lung Cancer
    Vidaza to Restore Hormone Thx Prostate
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Prostate Cancer
    First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Bladder Cancer, Transitional Cell Carcinoma, Metastasis
    A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Neoplasms
    TroVax Renal Immunotherapy Survival Trial
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Clear Cell Renal Carcinoma
    Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)
    Virginia Oncology Associates

    Trial Locations
    Virginia Oncology Associates
    Peninsula Cancer Institute
    Prostate Cancer
    Study of the Safety of GCS-100 in Subjects With Chronic Lymphocytic Leukemia
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Chronic Lymphocytic Leukemia
    Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Melanoma
    RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Brain Metastases
    Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Breast Cancer
    PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer
    Peninsula Cancer Institute - Newport News Office
    Newport News, Virginia 23601
    Lung Cancer
    Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Prostate Cancer
    AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Small Cell Lung Cancer
    LBH589 Treatment for Refractory Clear Cell Renal Carcinoma
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Renal Cell Carcinoma
    A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Human Mammary Carcinoma
    A Phase 1-2 XIAP Antisense AEG35156 With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Carcinoma, Non-Small-Cell Lung
    Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast Cancer
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Breast Cancer
    Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Non-Small Cell Lung Cancer
    A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)
    Virginia Oncology Associates

    Trial Locations
    Virginia Oncology Associates
    Peninsula Cancer Institute
    Extensive-stage Small Cell Lung Cancer